Manganese superoxide dismutase (Mn-SOD) plays a major role in protecting mitochondria from oxidative damage. Overexpression of Mn-SOD maintains cell survival under conditions that lead to apoptotic death. In addition to the antioxidative enzyme, platelet-derived growth factor (PDGF) is a principal survival factor that inhibits apoptosis and promotes proliferation by activating survival signaling pathways in various cells. Here we show that PDGF induced the expression of the Mn-SOD gene in NIH3T3 cells, and its induction was associated with early growth response-1 (Egr-1), a transcription factor. An electrophoretic mobility shift assay demonstrated that Egr-1 bound to the proximal promoter of the Mn-SOD gene in response to PDGF. The proximal promoter region of Mn-SOD was shown to be transcriptionally responsive to both basal and PDGF stimulation by transfection studies. Forced expression of Egr-1 in the cells activated Mn-SOD transcription in a dose-dependent manner. The pathway by which PDGF induced Egr-1 involved the mitogen-activated protein kinase kinase-1 (MEK1) and extracellular signal-regulated kinases 1 and 2 (ERK1/2), because the effect of PDGF on the induction of Egr-1 was blocked by U0126, a specific MEK1 inhibitor. These findings indicate that the induction of Mn-SOD is part of the anti-apoptotic properties mediated by PDGF.
ging is associated with the decline of many physiological functions. Reactive oxygen species (ROS) 2 have been assumed to attack membrane lipids, DNA, and proteins and lead to age-related changes of several physiological functions (1−3) . Cellular defenses against oxidative stress have shown a strong positive correlation between the maximum life span potential of species and their antioxidant capacity (3−6) . Superoxide dismutases (SODs) are important metalloenzymes that scavenge superoxide radicals through disproportion (7) . Three types of SODs with distinctive distributions are known to exist. The copper-zinc SOD (CuZn-SOD) is found mainly in the cytosol of eukaryotes; the iron SOD is found in prokaryotes, eukaryotic algae, and higher plants; and the manganese SOD (Mn-SOD) is found in both prokaryotes and the mitochondria of eukaryotes. In Caenorhabditis elegans, mutations A of clk-1 (8, 9) and the genes of the dauer/insulin receptor signaling pathway, such as daf-2 (10) and age-1 (11−13) , survive longer and are more resistant to ROS, heat, and UV. A recent report has shown that the daf-2 gene network controls longevity by regulating the Mn-SOD-associated antioxidant defense system (6) . Overexpression of Mn-SOD confers enhanced resistance to the cytotoxicity of tumor necrosis factor (14−17) . Conversely, Mn-SOD-deficient mice die in less than three weeks (18, 19) . Evidence indicates that antioxidant defense mechanisms have important roles in the aging process.
Regulation of cell survival is crucial to the aging process and the normal physiology of multicellular organisms. Our understanding of the machinery of cell survival has advanced in the past several years. Growth factors, including the neurotrophins, insulin-like growth factor-1 (IGF-1), and platelet-derived growth factor (PDGF), can promote cell survival in various experimental cell systems. Phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway and mitogen-activated protein kinase (MAPK) cascade activated by these factors have been involved in the mechanism of cell survival (20−23) . The relationship between antioxidant defenses and survival-signaling pathways mediated by growth factors, however, has not been understood.
We hypothesized that growth factors may induce Mn-SOD gene expression and may thereby enhance cellular resistance to oxidative stress. In this report, we show that PDGF induced Mn-SOD transcription in NIH3T3 cells. This induction was regulated by early growth response-1 (Egr-1), a transcription factor (24) . After PDGF treatment, Egr-1 bound to the proximal promoter region of Mn-SOD gene that contains several GC-boxes. Promoter analyses showed that PDGF stimulation or forced expression of Egr-1 activated Mn-SOD transcription through the proximal promoter. PDGF activated both PI3K-Akt and the mitogen-activated protein kinase kinase-1 (MEK1) and extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling pathway in the cells. U0126, a specific inhibitor of MEK1, inhibited the effects of PDGF on the induction of Egr-1 and the activation of Mn-SOD transcription, whereas wortmannin, a specific inhibitor of PI3K, did not. These findings indicate that the mechanism of Mn-SOD transcription mediated by PDGF involved the MEK1-ERK1/2 signaling pathway and its downstream transcription factor, Egr-1.
METHODS

Materials
Cell culture reagents and calf serum were obtained from Gibco-BRL (Life Technologies, Inc., Gaithersburg, MD). Recombinant murine PDGF-AB was purchased from R&D Systems (Minneapolis, MN). Antibodies were obtained from the following sources: anti-ERK2, anti-Egr-1, anti-Sp1, and Sp3 from Santa Cruz Biotechnology (Santa Cruz, CA), and anti-phospho-ERK1/2, anti-phospho-Akt, anti-Akt, horseradish peroxidase (HRP), conjugated-anti-rabbitimmunoglobulin G, and HRP conjugated-anti-mouse-immunoglobulin G from New England Biolabs (Beverly, MA). A Sp1 consensus oligonucleotide and an Egr-1 consensus oligonucleotide were obtained from Santa Cruz Biotechnology. A PI3K inhibitor, wortmannin, was obtained from Sigma Chemical Co. (St. Louis, MO). A MEK1 inhibitor, U0126, was purchased from Calbiochem (La Jolla, CA).
Cell culture
NIH3T3 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% calf serum, 100 units/ml penicillin, and 100 µg/ml streptomycin.
RNA isolation and analysis
The cells were preincubated in fresh serum-free medium for 24 h before the treatments. Total cytoplasmic RNA was isolated using the guanidine isothiocyanate method from the cells that were left untreated or treated with 10 or 50 ng/ml PDGF for 2, 6, 12, or 24 h. Samples of 10 µg of total RNA were denatured, separated by electrophoresis in a 1% agarose gel containing formaldehyde, and transferred to GeneScreen membranes (DuPont, Boston, MA). The membranes were prehybridized and then hybridized with a Mn-SOD cDNA probe (25) labeled with [α-32 P] dCTP (NEN) using a random primer labeling system (Pharmacia Biotech, Buckinghamshire, U.K.). After hybridization, the membranes were washed and exposed to X-ray film (Fuji Film). All blots were rehybridized with a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe to normalize for mRNA loading differences. To quantify the contents of mRNA in the cells, the membranes were exposed to imaging plates (Fuji Film), and radioactivities were measured with a bioimage analyzer, Fijix BAS 1500 (Fuji Film).
Plasmid constructs
The mouse Mn-SOD promoter luciferase reporter plasmids were constructed as described previously (26) . For the construction of reporter plasmids containing mutated sequences in transcription factor binding sites, site-specific mutagenesis was performed by a polymerase chain reaction (PCR)-based protocol. The expression vector for Sp1 (pCGN-Sp1) encoding the fulllength cDNA of human Sp1 and its backbone vector (pCGN) were kind gifts from Thomas Shenk, Princeton University (27) . pCGN-Sp3 encoding the full-length cDNA of human Sp3 was described previously (28) . A constitutive expression vector of MEK1 (pCMV-MEK1) was purchased from CLONTECH (Palo Alto, CA). A full-length mouse Egr-1 cDNA (24) was generated by reverse transcriptase-polymerase chain reaction (RT-PCR) with mRNA from PDGFtreated cells as a template. The primers used for RT-PCR were 5′−GCTCGCTGGTCCGGGATGGCAGCGGCC−3′ (sense) and 5′−CTTTTATTCCCTTTAGCAAATTTCAA−3′ (antisense). The PCR product was subcloned into the pCR TM 2.1 (Invitrogen, Carlsbad, CA), digested with BamHI and XhoI, gel-purified, and ligated into a BamHI-XhoI-digested pcDNA3 (Invitrogen) to generate pcDNA-Egr-1. A Egr-1 cDNA encoding amino acids 319-418 with a EcoRI site added at the 5′ terminus and a SmaI site at the 3′ terminus was made by PCR with the full-length mouse Egr-1 cDNA as a template. Primer sequences were 5′-CCGGAATTCCGATGCGCAAGTACCCCAAC-3′ (sense) and 5′-TCCCCCGGGGGATTATCTTAAATGGATTTTGGT-3′ (antisense). The PCR product was digested with EcoRI and SmaI, gel-purified, and ligated into an EcoRI-EcoRV-digested pcDNA3 to generate pcDNA-Egr-ZF. pcDNA-Egr-1 and pcDNA-Egr-ZF were sequenced to confirm their fidelity.
Transfection assays
Transient transfection of NIH3T3 cells was carried out using SuperFect reagent (Qiagen, Hilden, Germany) as previously described (26) . In general, the day before transfection, 4 × 10 5 cells were plated in 12-well tissue culture plates supplemented with fresh medium before transfection. A total of 2.5 µg of DNA consisting of 2.25 µg of the indicated luciferase plasmid and 0.25 µg of the pRL-thymidine kinase control vector (pRL-TK) (Promega, Madison, WI) per plate was used for transfection studies with reporter plasmids. After transfection, the cells were placed in serum-free medium for 24 h; 10 ng/ml PDGF or control buffer was then added for another 16 h. In some experiments, cells were preincubated with 50 µM U0126 or 100 nM wortmannin for 1 h and then exposed to 10 ng/ml PDGF for 16 h. For cotransfection studies, cells grown in 12-well plates were transfected with 1.8 µg of luciferase reporter plasmid, 0.2 µg of pRL-TK, and 1 µg of the indicated expression plasmids. pCGN, pcDNA3, or pCMV was used to adjust the total amount of expression plasmid DNA. The cells were placed in serum-free medium for 24 h. For cotransfection studies with pcDNA-Egr-ZF plasmid, the cells were placed in serum-free medium for 24 h after cotransfection; 10 ng/ml PDGF or control buffer was then added for another 16 h. After being harvested, the cells were assayed by the Dual-Luciferase Reporter Assay System (Promega), using a luminometer (EG&G Berthold, Bad Wildbad, Germany). Protein concentrations of the cell lysates were determined by the Bradford method with the Bio-Rad (Hercules, CA) protein assay dye reagent. Promoter activities were expressed as relative light units (RLUs), normalized against the concentration of the protein. All transfection experiments were repeated at least three times.
Nuclear extract preparation
Nuclear extracts were prepared from the cells that were left untreated or treated with 50 ng/ml PDGF for 1 h using the rapid preparation as previously described (26) . In some experiments, cells were preincubated with 50 µM U0126, 100 nM wortmannin, or an equal volume of dimethyl sulfoxide (DMSO) for 1 h and then exposed to 50 ng/ml PDGF for 1 h. The protein concentrations of the nuclear fractions were determined by the Bradford assay, and all extracts were stored at −70ºC.
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSAs) were performed using 3 µg of nuclear extract from either untreated or PDGF-treated cells. Synthetic complementary oligonucleotides with a G overhang were annealed and labeled with [.- 32 P] dCTP, using the Klenow fragment. DNA binding reactions were performed as previously described (26) . Twenty nanograms of Egr-1 or Sp1 consensus oligonucleotide or a 200-fold molar excess of oligonucleotides containing mutated sequences was used as an unlabeled competitor. For EMSAs using antibodies, nuclear extracts were preincubated with antibodies (0.2−0.4 µg per reaction) for 20 min at 4°C. The reactions were separated on 5% polyacrylamide gels. Gels were dried and subjected to autoradiography. The following pairs of oligonucleotides were used 
Western blot analysis
Cells untreated or treated with 50 ng/ml PDGF for 5, 10, 20, 40, 60, or 120 min were lysed in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 137 mM NaCl, 2 mM EDTA, 10% (vol/vol) glycerol, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 1 mM sodium vanadate, and 1% (vol/vol) Triton X-100. In some experiments, cells were preincubated with 50 µM U0126, 100 nM wortmannin, or an equal volume of DMSO for 1 h and then exposed to 50 ng/ml PDGF for 20 min. Protein concentration was determined by the Bradford assay. Each cell lysate containing 25 µg protein was run under reducing conditions in 8% sodium dodecyl sulfate-polyacrylamide electrophoresis gels (SDS-PAGE), transferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA) and reacted with antibodies as described. The primary antibody was detected by counterstaining with a HRP-linked antibody and visualized by enhanced chemiluminescence. Nuclear extracts (20 µg) were subjected to SDS-PAGE and Western blotting.
Statistics
Statistical analysis was performed using ANOVA (StatView, Abacus Concepts, Cary, NC), and probability values (P) below 0.05 were considered to be statistically significant.
RESULTS
PDGF induces synthesis of Mn-SOD mRNA
NIH3T3 cells were treated with or without PDGF for the indicated time to examine the effect on Mn-SOD gene expression. As shown in Figure 1 , Mn-SOD mRNA was increased slightly in the first 2 h with 50 ng/ml PDGF treatment. The level of Mn-SOD mRNA in PDGF-treated cells peaked at 6 h with a twofold induction versus the level in the untreated cells, followed by a gradual decrease afterward. Similar results were obtained from the cells treated with 10 ng/ml PDGF (data not shown).
Mn-SOD promoter contains regulatory DNA elements responsive to PDGF
We have constructed a series of 5' end deletion mouse Mn-SOD promoter luciferase reporter plasmids. Each plasmid containing its transcription initiation sites was transiently transfected into NIH3T3 cells and then treated with 10 ng/ml PDGF for 16 h. The promoter activity was normalized against the concentration of the protein, because the activity of pRL-TK control vector was induced by PDGF. As shown in Figure 2 , constructs containing 231 bp, 250 bp, 538 bp, and 1452 bp of 5' flanking DNA exhibited a high level of relative luciferase activity in the untreated cells, and the activity was increased significantly by the treatment with 10 ng/ml PDGF. Transfection with Mn-pro (−190) induced a small increase of the luciferase activity in the untreated cells, but the activity did not increase significantly by PDGF stimulation. Deletion up to the position of −170 resulted in a drastic decrease of the luciferase activity in both untreated and PDGF-treated cells. These transfection studies indicated that the Mn-SOD promoter region nucleotide between −250 and −170 was responsible for the basal and PDGF-induced transcription.
Sp1 family proteins and Egr-1 bind to Mn-SOD proximal promoter region
EMSAs were carried out with nuclear extracts prepared from the NIH3T3 cells that were either untreated or treated with 50 ng/ml PDGF for 1 h. Because the transfection studies indicated that the −250 to −170 bp region in the Mn-SOD promoter was responsible for the basal and PDGFinduced transcription, we used four different probes spanning nucleotides −192 to −162, −219 to −185, −212 to −234, or −263 to −235. Nuclear extracts from untreated or PDGF-treated cells incubated with Mn-P (−212 to −234) did not form any specific complex (data not shown). Several DNA-protein complexes were observed using the rest of the three probes. Nuclear extracts from the untreated cells formed major two bands using 32 P-labeled Mn-P (−192, −162) (Fig. 3A) and Mn-P (−219, −185) (Fig. 3B ) and three bands using 32 P-labeled Mn-P (−263, −235) (Fig. 3C) . Binding of the protein complexes with the Mn-P (−192, −162) or the Mn-P (−219, −185) probe was blocked by an excess of a Sp1 consensus oligonucleotide as an unlabeled competitor. An anti-Sp1 antibody mainly blocked to form the upper band of the major two bands, and anti-Sp3 antibody blocked the lower band. Although we failed to identify a protein forming a third band with Mn-P (−263, −235), the major two complexes also disappeared because of an excess of an unlabeled Sp1 consensus oligonucleotide and by adding anti-Sp1 and -Sp3 antibodies. These results suggested a possible involvement of Sp1 family proteins in the assembly of the two complexes. Nuclear extracts from the PDGF-treated cells interacted with the three probes and formed an additional complex between the Sp1-and Sp3-related complexes. This additional complex disappeared because of an excess of an Egr-1 consensus oligonucleotide or an anti-Egr-1 antibody, suggesting a possible involvement of Egr-1 in the assembly of the PDGF-induced complex. The PDGF-induced protein apparently interacted with Mn-P (−192, −162) and Mn-P (−263, −235) but only slightly with Mn-P (−219, −185). On the other hand, constitutively expressed Sp1-related complexes appeared to interact strongly with Mn-P (−219, −185) and Mn-P (−192, −162), but minor interaction was observed with Mn-P (−263, −235). PDGF treatment did not change the binding pattern and intensity of Sp1-related complexes in an obvious way.
These results showed that Egr-1 bound to three distinct sites of the Mn-SOD proximal promoter after PDGF stimulation, whereas the Sp1 family proteins bound to the gene constitutively. To identify Sp1-and Egr-1-binding sites within the proximal promoter, we used oligonucleotides containing mutated sequences as a competitor. Oligonucleotides M1, M2, and M3 did not compete for Egr-1 binding with the Mn-P (−192, −162) probe, whereas oligonucleotide M4 did. On the other hand, M2, M3, and M4 did not compete for Sp1 binding with the Mn-P (−192, −162) probe, whereas M1 did. Binding of the Sp1-related complexes with the Mn-P (−219, −185) probe was not completely blocked by competitors M8 and M9. The minor interaction of the Egr-1-related complex with the Mn-P (−219, −185) probe was not blocked by competitor M7. Competitors M11, M12, M13, and M14 failed to compete for Sp1 binding to Mn-P (−263, −235), and M13 and M14 did not compete for Egr-1 binding. It is interesting that Sp1 binding with the Mn-P (−192, −162) probe was increased by the addition of anti-Egr-1 antibody or unlabeled Egr-1 consensus oligonucleotide. These results showed that the binding elements of Egr-1 and Sp1 family proteins overlapped but were not identical.
Sp1 proteins and Egr-1 activates the Mn-SOD transcription through the proximal promoter
To define the functional significance of these DNA-protein complexes, we performed cotransfection studies. As shown in Figure 4 
PDGF-induced Mn-SOD transcription mediated by Egr-1
As shown in Figure 5A , cotransfection of pcDNA-Egr-1 with Mn-pro (−250) induced the luciferase activities in a dose-dependent manner. To determine whether Egr-1 mediates Mn-SOD transcription induced by PDGF, we constructed pcDNA-Egr-ZF that contains a DNA binding domain but lacks the activation domain. Cotransfection of the empty vector (pcDNA3) with Mnpro (−250) into the cells resulted in a high level of relative luciferase activity in the untreated cells, and the activity was increased significantly by treatment with 10 ng/ml PDGF (Fig. 5B) . Cotransfection of pcDNA-Egr-ZF resulted in a gradual decrease of the PDGF-activated luciferase activities in a dose-dependent manner until they ceased altogether. Furthermore, cotransfection with pcDNA-Egr-ZF also decreased the luciferase activities in the untreated cell in a dose-dependent manner. These results indicated that Egr-1 was a transcription factor to activate Mn-SOD transcription in response to PDGF and that the binding elements of Egr-1 and Sp1 family proteins might overlap in the Mn-SOD promoter.
A 250-bp fragment of Mn-SOD proximal promoter contained three GC clusters that were bound with Sp1 family proteins and the Egr-1 protein (Fig. 3) . To examine the role of these ciselements more precisely, we performed luciferase assays with reporter plasmids containing sitespecific mutations, which were introduced into the Mn-pro (−250) (Fig. 6) . The cells were cotransfected with one of the expression vectors for Sp1 (pCGN-Sp1), Egr-1 (pcDNA-Egr-1), or the empty vector (pCGN) together with reporter plasmids containing mutations ( Table 1) . The mutations of the B, C, and E reduced the transcriptional activity in the cells transfected with pCGN (mu 2, mu 8, mu 9, and mu 10). In particular, mutations of C and E (mu 10) led to a remarkable reduction of transcriptional activity compared with that of the cells transfected with Mn-pro (−250). The luciferase activity induced by cotransfection of pCGN-Sp1 or pcDNA-Egr-1 with mu 8, mu 9, or mu 10 was lower than that induced by the cotransfection with other reporter plasmids. These results indicated that two apparent Sp1 binding sites shown in EMSAs were the most essential cis-elements for basal transcription of the Mn-SOD gene in NIH3T3 cells. In contrast, the mutation of A or D (mu 1 and mu 3) that disrupted the major Egr We performed luciferase assays with reporter plasmids containing the site-specific mutations to clarify the cis-elements for PDGF-mediated Mn-SOD transcription. Although a single mutation of A, B, or D (mu 1, mu 2, and mu 3) did not reduce PDGF-induced Mn-SOD transcriptional activity, mutation of both A and B (mu 4) abrogated PDGF-induced Mn-SOD transcriptional activity (Table 2) . Egr-1 binding elements that enhance transcription of the Mn-SOD gene were located from −207 to −205 and from −243 to −238 in the proximal promoter. These results were consistent with those of transfection studies using a series of 5' end deletion reporter plasmids ( Fig. 2 and 4 ). Sp1 protein was indispensable for basal and PDGF-mediated Mn-SOD transcription, because transfection with mu 8, mu 9, or mu 10 into the cells also did not induce the luciferase activities after PDGF stimulation. In particular, the disruption of the major Sp1 binding site located from −182 to −176 failed to activate Mn-SOD transcription.
MEK1-ERK1/2 pathway involves Mn-SOD transcription mediated by PDGF
PDGF induced phosphorylations of both ERK1/2 and Akt within 5 min in the cells (data not shown). To determine the more prominent pathway by which PDGF activates Mn-SOD transcription through the proximal promoter, we examined the effect of PDGF on Mn-SOD transcriptional activity in the presence of a specific MEK1 inhibitor, U0126, or a specific PI3K inhibitor, wortmannin. PDGF-induced Mn-SOD transcription was suppressed in the cells pretreated with 50 µM U0126 but not with wortmannin (Fig. 7A) . In addition, cotransfection of constitutively expressed MEK1 (pCMV-MEK1) with Mn-pro (−250) produced a twofold induction of luciferase activity compared with the level in the cells cotransfected with the empty expression vector (pCMV) (Fig. 7B) . These results demonstrated that PDGF-mediated Mn-SOD transcription through the proximal promoter involved a MEK1-ERK1/2 signal pathway because the effect of PDGF on Mn-SOD transcription was blocked by U0126, a specific MEK1 inhibitor, and Mn-SOD transcription was induced by cotransfection with constitutively active MEK1.
Egr-1 expression is dependent on MEK1-ERK1/2 pathway
To confirm Egr-1 as a downstream component of the MEK1-ERK1/2 pathway, we subjected nuclear extracts to SDS-PAGE and Western blot analysis. As shown in Figure 8A , Sp1 family proteins were expressed constitutively in nuclear extracts prepared from both untreated and PDGF-treated cells. The expression of Sp1 mRNA was not changed by PDGF treatment (data not shown). In contrast, Egr-1 was induced in the nuclear extracts prepared from PDGF-treated cells. After PDGF stimulation, the induction of Egr-1 mRNA and protein were detected within 30 min and 1 h, respectively, and gradually decreased (data not shown). PDGF-induced Egr-1 expression was dependent on the MEK1-ERK1/2 pathway because the effect of PDGF on the Egr-1 expression was blocked by U0126, a specific MEK1 inhibitor (Fig. 8B) . Wortmannin, a specific PI3K inhibitor, did not inhibit the activation of Egr-1, suggesting that the PI3K-Akt pathway was unrelated to Egr-1 activation. Phosphorylation of ERK1/2 was blocked completely by 50 µM U0126, and phosphorylation of Akt was completely inhibited by 100-nM wortmannin in the cells (data not shown).
DISCUSSION
In this study we demonstrated that PDGF-induced Mn-SOD transcription was mediated by Egr-1, a zinc finger DNA-binding protein that interacts with a consensus GC-rich region. PDGFinduced Egr-1 expression preceded the induction of Mn-SOD transcription. The Mn-SOD promoter region nucleotide between −250 and −170 that contains several GC-boxes was responsive to both basal and PDGF-induced promoter activities. Sp1, Sp3, and Egr-1 bound to three distinct regions in the Mn-SOD promoter. The binding elements of Egr-1 and Sp1 family proteins overlapped but were not identical. The binding affinity of Egr-1 for the three distinct regions in the Mn-SOD gene was different from that of the Sp1 family proteins in vitro shown in EMSAs. Cotransfection of pcDNA-Egr-ZF containing a DNA binding domain of Egr-1 without its activation domain decreased the Mn-SOD transcription in both the untreated and PDGFtreated cells. These findings indicated that not only Egr-1 but also Sp1 was displaced from the Mn-SOD promoter by overexpression of the DNA binding domain of Egr-1, resulting in the decrease of basal promoter activity in the untreated cells.
Khachigian et al. investigated the interaction of Egr-1 and Sp1 overlapping binding elements in the proximal PDGF-B promoter (30) . In their report, Sp1 was displaced from the promoter by Egr-1 in a dose-dependent manner. A major Egr-1 binding site located from −182 to −174 within the Mn-SOD proximal promoter (Fig. 3A) did not contribute to activating the Mn-SOD transcription in response to PDGF, but the other Egr-1 binding sites located from −207 to −205 and from −243 to −238 did (Table 2 ). These observations indicate that elevated amounts of nuclear Egr-1 in response to PDGF may block the binding of Sp1 that is required for the basal and PDGF-mediated transcription of Mn-SOD. Competition between Egr-1 and Sp1 proteins for binding to the essential cis-element located from −185 to −174 in the Mn-SOD promoter may result in PDGF-induced Mn-SOD transcription that is less than twofold. Overexpression of EgrPDGF led to simultaneous phosphorylation of both ERK1/2 and Akt within 5 min in NIH3T3 cells. U0126, a specific MEK1 inhibitor, completely blocked the induction of the Egr-1 mRNA and protein after PDGF stimulation, whereas wortmannin, a specific PI3K inhibitor, did not. These results indicated that PDGF-induced Egr-1 expression was dependent on the MEK1-ERK1/2 signaling pathway. Previous reports have shown that Egr-1 activation is implicated in the coordinated expression of endothelial proteins such as PDGF-A, PDGF-B, and transforming growth factor-β (TGF-β), which are involved in vascular remodeling after injury (30−33) . A variety of extracellular stimuli, including growth factors, physical forces, and injurious stimuli, rapidly activate the Egr-1 that is dependent on the MEK1-ERK1/2 signaling pathway, and Egr-1 binds to a sequence found in the promoters of these genes. Our study was consistent with the previous works. Gimbrone and his colleagues have reported that Mn-SOD is selectively upregulated by steady laminar shear stress in human endothelial cells (34) . Taken together with our results, Egr-1 itself may be up-regulated by shear stress and play an important role in upregulation of Mn-SOD in the endothelial cells. CuZn-SOD, which participates in the control of intracellular concentrations of reactive oxygen intermediates, is one of the Egr-1-dependent genes because the Egr-1 binds to a sequence in the proximal promoter of the gene (35) . Thus, both Mn-SOD and CuZn-SOD genes with potential protective (antioxidant) activities are regulated by Egr-1. We could not clearly ascertain whether Sp1 binding to the essential ciselement (−182 to −176) of the Mn-SOD promoter in response to PDGF was dependent on Sp1 phosphorylation by the MEK1-ERK1/2 cascade (36), because Sp1 binding to the cis-element was affected by the PDGF-induced Egr-1 protein.
In addition to phosphorylation of ERK1/2 and Akt, activation of the nuclear factor-κB (NF-κB) has been implicated in various anti-apoptotic signaling pathways (37−39) . A recent report showed that NF-κB is a target of Akt in anti-apoptotic PDGF signaling (40) . Several groups, including ours, have reported that the Mn-SOD gene contains a NF-κB binding site that is responsive to cytokines and bacterial endotoxins within the second intron (26, 41−43) . These findings suggest that the phosphorylated form of Akt may activate the NF-κB that enhances the transcriptional activity of the Mn-SOD gene through the intronic enhancer region. We attempted to examine the possible involvement of NF-κB on PDGF-mediated Mn-SOD transcription through the intronic enhancer region by transfection studies. However, PDGF-induced transcriptional activity was not changed in the cells transfected with plasmid containing the wildtype 302 bp fragment in the intronic enhancer region of the Mn-SOD gene or containing a mutation within the NF-κB binding site that is highly responsive to tumor necrosis factor-α (TNF-α) within the intronic enhancer region (K. Maehara and K. Isobe, unpublished data). This result suggests that NF-κB has little effect on PDGF-mediated Mn-SOD transcription. We did not detect the relationship between PI3K-Akt-NF-κB signaling and PDGF-induced Mn-SOD transcription. Recently, Rommel et al. demonstrated that the Raf-MEK-ERK pathway and Akt had opposing effects on muscle cell hypertrophy (44) . Zimmermann and Moelling showed that the phosphorylation of c-Raf by Akt inhibited activation of the Raf-MEK-ERK signaling pathway (45) . These observations provide a cross talk between Raf-MEK-ERK and PI3K-Akt signaling pathways.
The accumulation of oxidative cellular damage is a major cause of aging in both invertebrates and mammals. Enhanced resistance to environmental stress contributes to extending individual life span in invertebrates (5) . With its short life span and complete genome sequence, C. elegans is becoming an important system for genetic studies on aging. C. elegans proceeds through four larval stages to become adult. Environmental cues such as insufficient food, crowding, and heat lead to the formation of a dispersal form, the dauer larva. Mutations of daf-2, a homologue of a member of the insulin receptor family, and age-1, a homologue of the mammalian PI3K, confer not only the constitutive dauer formation phenotype but also the life extension phenotype (10, 11) . These effects are entirely suppressed by a mutation in daf-16 that encodes a forkhead family transcription factor (12, 46, and 47) . C. elegans has two Mn-SOD genes, sod-2 (expressed at almost the same level in both the adult and dauer stage) and sod-3 (expressed specifically in the dauer stage). The defects in the insulin-like signaling pathway up-regulate sod-3 mRNA by activating the daf-16 gene (6). The importance of cellular defenses against oxidative stress is apparent in mammals because overexpression of Mn-SOD confers resistance to the cytotoxicity of TNF in some human cell lines (14−17) and because Mn-SOD-deficient mice are lethal (18, 19) . However, the biological significance of the relationship between cell survival signaling and Mn-SOD gene expression to extend life span in mammals is not clearly understood, and few genes are known to increase individual life span in mammals. Here, we demonstrate that stimulation by a growth factor, PDGF, could induce the expression of the Mn-SOD gene by activating a cell survival signaling MEK1-ERK1/2 cascade in a cultured cell system. Although we show no direct evidence that PDGF-induced Mn-SOD transcription could contribute to extending individual life span in mammals, our findings help explain the mechanism by which PDGF-activated transcription of the Mn-SOD gene underlies cell survival processes. Because the promotion of cell survival depends on the integration of multiple signaling pathways, further studies are needed to clarify how individual life spans can be extended by regulating mammals' stress responses as they age. PDGF for the indicated time. The cells were harvested, and total RNA was isolated. Ten micrograms of total RNA was subjected to Northern blot analysis using a Mn-SOD cDNA probe followed by a GAPDH probe to normalize for loading differences. preincubated for 1 h with or without 50 µM U0126, 100 nM wortmannin, or an equal volume of DMSO, and then stimulated with 50 ng/ml PDGF for 1 h. Nuclear extracts were analyzed by immunoblotting with antibodies against Egr-1, Sp1, and Sp3. B) The cells were preincubated for 1 h with or without 50 µM U0126, 100 nM wortmannin, or an equal volume of DMSO, and then stimulated with 50 ng/ml PDGF for 20 min. Phosphorylated forms of ERK1 and 2 in cell lysates were detected with phosphopeptide-specific antibody. The membrane was stripped and probed with antibody against ERK2 to confirm that similar amounts of cell lysates were analyzed.
